167 related articles for article (PubMed ID: 28796993)
1. Oral Administration of CardioAid and Lunasin Alleviates Liver Damage in a High-Fat Diet Nonalcoholic Steatohepatitis Model.
Drori A; Rotnemer-Golinkin D; Zolotarov L; Ilan Y
Digestion; 2017; 96(2):110-118. PubMed ID: 28796993
[TBL] [Abstract][Full Text] [Related]
2. Altered distribution of regulatory lymphocytes by oral administration of soy-extracts exerts a hepatoprotective effect alleviating immune mediated liver injury, non-alcoholic steatohepatitis and insulin resistance.
Khoury T; Ben Ya'acov A; Shabat Y; Zolotarovya L; Snir R; Ilan Y
World J Gastroenterol; 2015 Jun; 21(24):7443-56. PubMed ID: 26139990
[TBL] [Abstract][Full Text] [Related]
3. Oral administration of a non-absorbable plant cell-expressed recombinant anti-TNF fusion protein induces immunomodulatory effects and alleviates nonalcoholic steatohepatitis.
Ilan Y; Ben Ya'acov A; Shabbat Y; Gingis-Velitski S; Almon E; Shaaltiel Y
World J Gastroenterol; 2016 Oct; 22(39):8760-8769. PubMed ID: 27818591
[TBL] [Abstract][Full Text] [Related]
4. Attenuating the rate of total body fat accumulation and alleviating liver damage by oral administration of vitamin D-enriched edible mushrooms in a diet-induced obesity murine model is mediated by an anti-inflammatory paradigm shift.
Drori A; Rotnemer-Golinkin D; Avni S; Drori A; Danay O; Levanon D; Tam J; Zolotarev L; Ilan Y
BMC Gastroenterol; 2017 Nov; 17(1):130. PubMed ID: 29179679
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
[TBL] [Abstract][Full Text] [Related]
6. Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver Disease in C57BL/6 Mice Model via AMPK/Sirt1/SREBP-1c/PPARγ Pathway.
Chyau CC; Wang HF; Zhang WJ; Chen CC; Huang SH; Chang CC; Peng RY
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31935815
[TBL] [Abstract][Full Text] [Related]
7. Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice.
Rodriguez-Echevarria R; Macias-Barragan J; Parra-Vargas M; Davila-Rodriguez JR; Amezcua-Galvez E; Armendariz-Borunda J
World J Gastroenterol; 2018 Jan; 24(4):461-474. PubMed ID: 29398867
[TBL] [Abstract][Full Text] [Related]
8. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.
Ganz M; Csak T; Szabo G
World J Gastroenterol; 2014 Jul; 20(26):8525-34. PubMed ID: 25024607
[TBL] [Abstract][Full Text] [Related]
9. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
Lee MR; Yang HJ; Park KI; Ma JY
Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
[TBL] [Abstract][Full Text] [Related]
10. Histological evaluation of nintedanib in non-alcoholic steatohepatitis mice.
Susutlertpanya W; Wakuda H; Otani N; Kuramoto T; Li L; Kuranari M; Sekiguchi A; Kudo H; Uchida T; Imai H; Uemura N
Life Sci; 2019 Jul; 228():251-257. PubMed ID: 31078545
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Deficiency of Augmenter of Liver Regeneration Predisposes to Nonalcoholic Steatohepatitis and Fibrosis.
Kumar S; Verma AK; Rani R; Sharma A; Wang J; Shah SA; Behari J; Salazar Gonzalez R; Kohli R; Gandhi CR
Hepatology; 2020 Nov; 72(5):1586-1604. PubMed ID: 32031683
[TBL] [Abstract][Full Text] [Related]
12. Genistein can ameliorate hepatic inflammatory reaction in nonalcoholic steatohepatitis rats.
Yin Y; Liu H; Zheng Z; Lu R; Jiang Z
Biomed Pharmacother; 2019 Mar; 111():1290-1296. PubMed ID: 30841442
[TBL] [Abstract][Full Text] [Related]
13. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
[TBL] [Abstract][Full Text] [Related]
14. Lycium ruthenicum extract alleviates high-fat diet-induced nonalcoholic fatty liver disease via enhancing the AMPK signaling pathway.
Lin J; Zhang Y; Wang X; Wang W
Mol Med Rep; 2015 Sep; 12(3):3835-3840. PubMed ID: 26017330
[TBL] [Abstract][Full Text] [Related]
15. Dolichos lablab Protects Against Nonalcoholic Fatty Liver Disease in Mice Fed High-Fat Diets.
Im AR; Kim YH; Kim YH; Yang WK; Kim SH; Song KH
J Med Food; 2017 Dec; 20(12):1222-1232. PubMed ID: 29090980
[TBL] [Abstract][Full Text] [Related]
16. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet.
Jeong MJ; Kim SR; Jung UJ
Nutr Res; 2019 Apr; 64():64-71. PubMed ID: 30802724
[TBL] [Abstract][Full Text] [Related]
17. Low fat but not soy protein isolate was an effective intervention to reduce nonalcoholic fatty liver disease progression in C57BL/6J mice: monitored by a novel quantitative ultrasound (QUS) method.
Rowles JL; Han A; Miller RJ; Kelly JR; Applegate CC; Wallig MA; O'Brien WD; Erdman JW
Nutr Res; 2019 Mar; 63():95-105. PubMed ID: 30824402
[TBL] [Abstract][Full Text] [Related]
18. Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
Chai C; Cox B; Yaish D; Gross D; Rosenberg N; Amblard F; Shemuelian Z; Gefen M; Korach A; Tirosh O; Lanton T; Link H; Tam J; Permyakova A; Ozhan G; Citrin J; Liao H; Tannous M; Hahn M; Axelrod J; Arretxe E; Alonso C; Martinez-Arranz I; Betés PO; Safadi R; Salhab A; Amer J; Tber Z; Mengshetti S; Giladi H; Schinazi RF; Galun E
Gastroenterology; 2020 Sep; 159(3):999-1014.e9. PubMed ID: 32450149
[TBL] [Abstract][Full Text] [Related]
19. Salicornia Extract Ameliorates Salt-Induced Aggravation of Nonalcoholic Fatty Liver Disease in Obese Mice Fed a High-Fat Diet.
Kim JH; Suk S; Jang WJ; Lee CH; Kim JE; Park JK; Kweon MH; Kim JH; Lee KW
J Food Sci; 2017 Jul; 82(7):1765-1774. PubMed ID: 28608557
[TBL] [Abstract][Full Text] [Related]
20. Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice.
Kim JK; Lee KS; Lee DK; Lee SY; Chang HY; Choi J; Lee JI
Exp Mol Med; 2014 Dec; 46(12):e127. PubMed ID: 25523099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
